-
Eric Schadt: Why Biology Needs a Steve Jobs
Aug 10, 2012, 08:35 AM by Michael CroftFull storyNature Biotechnology | Eric Schadt, director of Mount Sinai's new Institute for Genomics and Multiscale Biology, discusses his vision to spend $100 million launching Mount Sinai to the forefront of the genomics revolution—and why he's enlisting Wall Street quants, user interface gurus and Facebook's former data whiz to do it.
-
Nic Volker, Living on the Edge of Science
Aug 9, 2012, 10:10 AM by Michael CroftFull storyJS Online | Two years after exome sequencing prompted a life-saving cord blood transplant, 7-year-old Wisconsinite Nic Volker is enjoying school, real food, good health and life in general.
-
Clinical Trial is Favorable for Microarray Prenatal Gene Test
Aug 9, 2012, 08:40 AM by Michael CroftNew York Times | The use of microarrays for prenatal testing to detect more genetic problems in a fetus than standard kayrotype testing could be headed toward wider use after encouraging results from an NIH-sponsored clinical trial of more than 4,000 pregnancies.Full story -
Physicians May Not Be Social, But They are Interactive
Aug 9, 2012, 08:20 AM by Michael CroftForbes.com | The desire to understand physician behavior, identify Key Opinion Leaders, and reach those influencers in a measured way is of extreme importance to pharmaceutical executives, writes Jim Golden in his latest blog.Full story -
CardioDx Wins Medicare OK of Molecular Test for Heart Disease
Aug 8, 2012, 14:25 PM by Michael CroftXconomy | After three years marketing a new genetic test that can tell when a patient’s chest pain is a sign of serious heart disease, CardioDX has taken a big step forward by persuading Palmetto GBA, the national contractor for Medicare, to reimburse the company for its Corus CAD test.Full story -
Congratulations on Reaching the $1000 Genome
Aug 6, 2012, 11:00 AM by Michael CroftPolITigenomics | For all intents and purposes, argues David Dooling, we have already achieved the $1,000 human genome -- compared to the $1 billion or spent on the first human genome, the difference between $1,000 and $5,000 is just a rounding error. "So, congratulations, we did it!"Full story -
Quinten’s Savoir Faire Approach to Data Mining
Aug 3, 2012, 10:55 AM by Michael CroftFull storyBio-IT World | Quinten, a rapidly expanding French CRO, brings an innovative data-mining approach to much of the drug development pipeline – from early stage target identification to clinical trials and patient stratification. Here, Kevin Davies interviews Quinten CEO Alexandre Templier.
-
Drug Discovery Looks for Its Next Fix
Aug 3, 2012, 10:30 AM by Michael CroftHPC Wire | Supercomputing shows great promise to improve the process of drug discovery, not only to find better, safer drugs, but also to weed out those compounds that would eventually fail during clinical trials.Full story -
Five Steps for Handling your Big Data Hoard
Aug 3, 2012, 10:25 AM by Michael CroftEnterprise CIO Forum | Decades ago, valued data was handled in a very manual and individual manner. But the explosion of data sources has made most people hoarders, without a plan to leverage the value.Full story -
Russian Web Tycoon Launches World's Biggest Science Prize
Jul 31, 2012, 10:55 AM by Michael CroftThe Guardian | Yuri Milner, a Russian internet investor who quit his PhD in physics and made $1 billion investing in social networking firms such as Facebook, Twitter and Groupon, has launched a clutch of awards worth $3 million apiece to recognise advances in fundamental physics.Full story -
23andMe Seeks FDA Approval for Personal DNA Test
Jul 30, 2012, 14:40 PM by Michael CroftBloomberg Businessweek | Consumer genetics pioneer 23andMe has taken the first step towards seeking Food and Drug Administration approval of its personalized DNA test.Full story -
Sharp Dip in US Drug Approvals Forecast
Jul 30, 2012, 11:50 AM by Michael CroftPharma Times | The US Food and Drug Administration (FDA) will approve fewer novel drugs in 2012 than it did last year, as the industry faces a number of ongoing operational risks, according to a new report.Full story -
A New Chapter for the Consumer Genetics Conference
Jul 27, 2012, 09:35 AM by Michael CroftFull storyBio-IT World | Asked what prompted her to launch The Consumer Genetics Conference (CGC) three years ago, together with her friend John Boyce, Meredith Salisbury says simply, “Insanity.” Coming to their senses, the duo have partnered with CHI to produce the 2012 conference, which will be held October 3-5, 2012.
-
Complete Genomics Bundles Ingenuity Variant Analysis software
Jul 26, 2012, 17:05 PM by Michael CroftBio-IT World | Complete Genomics announced that it will bundle Ingenuity Systems’ Variant Analysis application with its research whole genome sequencing services.Full story -
John Reynders on the Role of R&D Information at AstraZeneca
Jul 25, 2012, 02:30 AM by Michael CroftBio-IT World | In his current role as head of R&D Information at AstraZeneca, John Reynders discusses the breadth of skills among his 400-strong team and the company’s commitment to innovation and long-range strategic planning.Full story -
Lasker Foundation Begins Search for Next President
Jul 24, 2012, 14:55 PM by Michael CroftFull storyBio-IT World | The Albert and Mary Lasker Foundation has embarked upon a global search for its next president to lead its operations, succeeding current chief Maria Freire, who is leaving this Fall.
-
23andMe DNA Mapping Reunites Long-Lost Siblings
Jul 24, 2012, 14:30 PM by Michael CroftCBS This Morning | Given up for adoption in 1960 at just 10 days, Neil Schwartzman suddenly traced his long-lost biological sister through the online DNA genotyping services of consumer genetics company 23andMe.Full story -
Ion Torrent Named First Entrant in Genomics X Prize Competition
Jul 23, 2012, 01:00 AM by Michael CroftBio-IT World | Organizers of the $10-million Archon Genomics X PRIZE competition, presented by Express Scripts, hope that the official entry of Ion Torrent will spur other next-gen sequencing hopefuls to sign up before the contest is held in September 2013.Full story -
New York Genome Center Inks Lease on 6th Avenue
Jul 20, 2012, 09:20 AM by Michael CroftThe Commercial Observer | The New York Genome Center has reportedly completed a deal to lease 150,000 square feet at 101 Avenue of the Americas.Full story -
Human Genes as Company Property Tested by Myriad Patent Case
Jul 19, 2012, 09:20 AM by Michael CroftBloomberg Businessweek | Madeleine Ball, a Harvard University geneticist, says entire regions of the human genome are at risk of becoming inaccessible to anyone who can’t afford to pay for patent licenses, stifling the information-sharing that is vital to scientific progress.Full story